Blue Jet Healthcare Limited
ListedMainboardIndustrial & Financial Services · NSE / BSE
Incorporated in 1968, Blue Jet Healthcare is a science-led pharmaceutical company specializing in healthcare ingredients and intermediates. The company was the first in India to manufacture saccharin and its salts and has since expanded into contrast media intermediates for CT scans and MRIs. Its main product categories include contrast media intermediates, high-intensity sweeteners, and pharmaceutical intermediates and APIs. Blue Jet Healthcare offers process development, production capabilities, global regulatory support, and collaboration in advanced pharmaceutical development. The company operates three manufacturing facilities in Shahad, Ambernath, and Mahad, Maharashtra, with annual installed capacities of 200.60 KL, 607.30 KL, and 213.00 KL, respectively, as of June 30, 2023.
Price Band
₹329 – ₹346
Issue Size
₹840 Cr
Lot Size
43 shares
GMP
₹22
+6.4%
Est. Listing
₹368
at current GMP
Subscribed
7.94x
overall
Open
25 Oct 2023
Close
27 Oct 2023
Allotment
30 Oct 2023
Refund
31 Oct 2023
Demat Credit
1 Nov 2023
Listing
1 Nov 2023
Last updated 12 days ago
Key Highlights
- •Leading player in the Indian market segment
- •Price band established at ₹329 - ₹346 per equity share
- •Minimum bid lot is 43 shares
- •Estimated listing target of ₹368 based on current grey market activity